During June 2022, the total number of shares and votes in the company has increased by 54,178,212, corresponding to 54,178,212 votes, whereof 52,516,260 common shares through the registration of the rights issue, 536,952 common shares through the directed issue to the guarantors in the rights issue and 1,125,000 shares as a result of an issue of class C shares. The newly issued class C shares have been repurchased and, by virtue of the conversion clause in the articles of association, converted to common shares, and are held by the company to secure its commitments under incentive programmes.
As per June 30[th], 2022, the last trading day in June, the total number of shares in Moberg Pharma AB (publ) amounts to 100,859,335. All shares are common shares. The total number of votes are 100,859,335. At the date of this press release, the Company holds 2,589,746 own common shares.
For additional information, please contact:
Anna Ljung, CEO, telephone: +46 707 66 60 30, e-mail:
Mark Beveridge, VP Finance, telephone: +46 76 - 805 82 88, e-mail:
About this information
The above information has been made public in accordance with the Swedish Financial Instruments Trading Act. The information was released for public distribution on June 30[th], 2022, at 8:00 am CEST.